Medicine guide

EYDENZELT

As listed in the register: EYDENZELT 40 mg/mL, solution injectable en flacon

40 mg · solution injectable

  • Prescription only
Active substance
Aflibercept
Made by
CELLTRION HEALTHCARE HUNGARY (HONGRIE)

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

How it works

From the US prescribing label for the same active substance (EYLEA). It describes the substance, not this exact product.

Vascular endothelial growth factor-A (VEGF-A) and placental growth factor (PlGF) are members of the VEGF family of angiogenic factors that can act as mitogenic, chemotactic, and vascular permeability factors for endothelial cells.

VEGF acts via two receptor tyrosine kinases, VEGFR-1 and VEGFR-2, present on the surface of endothelial cells.

Half-life5–6 days
Mostly cleared after≈ 4 weeksfive half-lives — our arithmetic

Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-07-07

Safety of the active substance

From the US prescribing label for the same active substance (EYLEA). It describes the substance, not this exact product.

Must not be used by
  • Hypersensitivity reactions may manifest as rash, pruritus, urticaria, severe anaphylactic/anaphylactoid reactions, or severe intraocular inflammation.
Most common side effects

The most common adverse reactions (≥5%) reported in patients receiving EYLEA were conjunctival hemorrhage, eye pain, cataract, vitreous detachment, vitreous floaters, and intraocular pressure increased.

Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

CanadaNo exact match for this strength and form

Details

Made byCELLTRION HEALTHCARE HUNGARY (HONGRIE)
Active substanceAflibercept
Strength40 mg
Formsolution injectable
Routeintravitréenne
Dispensing (as stated by the register)prescription réservée aux spécialistes et services OPHTALMOLOGIE · liste I
MarketedYes, according to the register
Reinforced monitoringYes — under reinforced monitoring, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/24/1895
Name in the registerEYDENZELT 40 mg/mL, solution injectable en flacon
Packs1 flacon en verre de 0,1 mlL + 1 aiguille filtre
CIS64127028
CIP133400930309698

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).

Other strengths and forms

2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.